Organigram Holdings Inc. Shareholders Equity (Total)

Shareholders Equity (Total) of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity (Total) growth rates and interactive chart. Shareholder equity, also referred to as shareholders' equity and stockholders' equity, it a corporation's owners' residual claim after debts have been paid. Equity is equal to a firm's total assets minus its total liabilities. It is found on a company's balance sheet and it's the total equity available to common shareholders (after accounting for preferred equity). Also called book value or net book value.


Highlights and Quick Summary

  • Shareholders Equity (Total) for the quarter ending August 31, 2022 was $388 Million (a -3.68% decrease compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity (Total) increased by 2.85%
  • Annual Shareholders Equity (Total) for 2022 was $388 Million (a 1.85% increase from previous year)
  • Annual Shareholders Equity (Total) for 2021 was $381 Million (a 66.54% increase from previous year)
  • Annual Shareholders Equity (Total) for 2020 was $229 Million (a -7.0% decrease from previous year)
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity (Total) of Organigram Holdings Inc.

Most recent Shareholders Equity (Total)of OGI including historical data for past 10 years.

Interactive Chart of Shareholders Equity (Total) of Organigram Holdings Inc.

Organigram Holdings Inc. Shareholders Equity (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $387.83 $402.65 $404.24 $387.83
2021 $377.1 $380.8 $401.44 $209.67 $380.8
2020 $242.02 $222.82 $229.11 $287.02 $228.65
2019 $248.72 $246.66 $250.94 $207.8 $245.87
2018 $178.08 $144.56 $142.0
2017 $65.38
2016 $33.79

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic